title: Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis.
authors: Pierre
authors: P
authors: Van Antwerpen
authors: Jean
authors: J
authors: Néve
authors: Patrick
authors: P
authors: Moreau
authors: Karim Zouaoui
authors: KZ
authors: Boudjeltia
authors: Michel
authors: M
authors: Vanhaeverbeek
authors: Martine
authors: M
authors: Prévost
authors: Sajida
authors: S
authors: Babar
authors: Ilham
authors: I
authors: Legssyer
authors: Nicole
authors: N
authors: Moguilevsky
authors: Jean
authors: J
authors: Ducobu
mesh_terms: D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D050197:Atherosclerosis / Q000503:physiopathology / Q000517:prevention & control*; D002712:Chlorides / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000187:drug effects / Q000378:metabolism*; D010084:Oxidation-Reduction / Q000187:drug effects; D009195:Peroxidase / Q000187:drug effects / Q000378:metabolism; D011341:Probucol / Q000008:administration & dosage / Q000494:pharmacology*; D013654:Taurine / Q000378:metabolism
chemical_list: D000924:Anticholesteremic Agents; D002712:Chlorides; D008077:Lipoproteins, LDL; D013654:Taurine; D006861:Hydrogen Peroxide; D009195:Peroxidase; D011341:Probucol